SYRINGA GENERAL HOSPITAL — History
CCN 131315 | 3-year financial timeline | COVID resilience: 70/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+15.2%
Revenue CAGR (3yr)
-9.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $20M | $20M | -1.2% | +15.2% |
| Operating Expenses | $17M | $20M | $22M | +6.1% | +14.1% |
| Operating Margin | -11.3% | -1.6% | -9.1% | -468.2% | +0.0% |
| Net Income | $-2M | $-0M | $-2M | -461.2% | +0.0% |
| Licensed Beds | 15 | 15 | 15 | +0.0% | +0.0% |
| Total Patient Days | 1,364 | 1,495 | 1,366 | -8.6% | +0.1% |
| Medicare Day % | 68% | 65% | 63% | -2.8% | -3.9% |
| Medicaid Day % | 13% | 12% | 16% | +35.6% | +12.8% |
COVID Impact & Recovery
Resilience Score: 70/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +32.7% ($15M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.2%
This Hospital
+7.6%
State Avg
Latest Margin
-9.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $22M | -8.1% |
| FY2024 (proj) | $25M | -7.0% |
| FY2025 (proj) | $27M | -5.9% |